Healthcare Triangle, Inc. Completes $2.0 Million Private Placement Debt Offering
02 Janvier 2024 - 3:15PM
Healthcare Triangle, Inc. (Nasdaq: HCTI) (“Healthcare
Triangle,” “HCTI” or the “Company”), a leader in digital
transformation solutions including managed services, cloud
enablement, cybersecurity, data analytics, and AI data processing
for the healthcare and life sciences industries, announced the
execution on December 28, 2023 of a securities purchase agreement
with an institutional investor for the sale of $2.0 million in
aggregate principal amount of its senior secured 15% original issue
discount convertible promissory notes, due June 28, 2025, along
with warrants to purchase 357,500 shares of common stock with an
exercise price of $3.44688 per share in a private placement
transaction (the “Offering”). Due to the original issue discount,
the Company received gross proceeds of approximately $1.7 million
and net proceeds, after deducting offering expenses, of
approximately $1.5 million. There may be additional potential
closings, for up to an additional $3.2 million aggregate principal
amount, subject to additional conditions detailed in the
transaction documents.
“This capital funding enables us to address a
number of unmet critical needs in the healthcare industry and
further builds upon the Company’s growth to become a premier
healthcare IT provider in the U.S. with its services and
offerings,” said Thyagarajan Ramachandran, Chief Financial Officer
of HCTI.
“The global healthcare IT market is projected to
surpass $970 billion by 2027. We are aware of the many challenges
facing healthcare and have a suite of services to fill the need and
demand. Our innovative solutions help organizations adopt a
cloud-first strategy to improve outcomes, quality, access and cost
of healthcare. With this added capital, we can further support key
initiatives, that are more important during this time.”
In connection with the Offering, the Company
relied upon the exemption from registration provided under Section
4(a)(2) and Rule 506(b) under the Securities Act of 1933, as
amended (the “Securities Act”), for transactions not involving a
public offering. The notes, any shares of common stock issuable
upon conversion of the notes, the warrants and any shares of common
stock issuable upon exercise of the warrants have not been
registered under the Securities Act, or under
any U.S. state securities laws or in any other
jurisdiction and may not be offered or sold in the United
States absent registration or an applicable exemption from the
registration requirements. The Company intends to file a
registration statement in the near future to register these
securities.
Additional details on the transaction are
available in the Company’s Form 8-K, which is being today filed
with the U.S. Securities and Exchange Commission and is
available at www.sec.gov.
This press release does not constitute an offer
to sell or the solicitation of an offer to buy these securities,
nor shall there be any sale of these securities in any state or
other jurisdiction in which such offer, solicitation or sale would
be unlawful prior to the registration or qualification under the
securities laws of any such state or other jurisdiction.
About Healthcare Triangle
Healthcare Triangle, Inc., based in Pleasanton,
California, reinforces healthcare progress through breakthrough
technology and extensive industry knowledge and expertise. We
support healthcare including hospitals and health systems, payers,
and pharma/life sciences organizations in their effort to improve
health outcomes through better utilization of the data and
information technologies that they rely on. Healthcare Triangle
achieves HITRUST Certification for Cloud and Data Platform (CaDP),
marketed as CloudEz™ and DataEz™. HITRUST Risk-based, 2-year (r2)
Certified status demonstrates to our clients the highest standards
for data protection and information security. Healthcare Triangle
enables the adoption of new technologies, data enlightenment,
business agility, and response to immediate business needs and
competitive threats. The highly regulated healthcare and life
sciences industries rely on Healthcare Triangle for expertise in
digital transformation encompassing the cloud, security and
compliance, identity management, data lifecycle management,
healthcare interoperability, and clinical and business performance
optimization. www.healthcaretriangle.com.
Forward-Looking Statements and Safe Harbor
Notice
All statements other than statements of
historical facts included in this press release are
“forward-looking statements” (as defined in the Private Securities
Litigation Reform Act of 1995). Such forward-looking statements
include our expectations and those statements that use
forward-looking words such as “projected,” “expect,” “possibility”
and “anticipate.” The achievement or success of the matters covered
by such forward-looking statements involve significant risks,
uncertainties and assumptions. Actual results could differ
materially from current projections or implied results. Investors
should read the risk factors set forth in the Company's Annual
Report on Form 10-K filed with the SEC on March 28, 2023,
subsequent filings and future reports filed with the SEC. All the
Company's forward-looking statements are expressly qualified by all
such risk factors and other cautionary statements.
The Company cautions that statements and
assumptions made in this news release constitute forward-looking
statements and make no guarantee of future performance.
Forward-looking statements are based on estimates and opinions of
management at the time statements are made. The information set
forth herein speaks only as of the date hereof. The Company and its
management undertake no obligation to revise these statements
following the date of this news release.
Contacts
Media:
Michael Campanamichael.c@healthcaretriangle.com
Investors:
1-800-617-9550
ir@healthcaretriangle.com
Healthcare Triangle (NASDAQ:HCTI)
Graphique Historique de l'Action
De Déc 2024 à Jan 2025
Healthcare Triangle (NASDAQ:HCTI)
Graphique Historique de l'Action
De Jan 2024 à Jan 2025